Rotavirus antigens

US8685411B2 · kind B2 · utility

Assignees

• Children's Medical Center Corporation · US
• The Board of Trustees of the Leland Stanford Junior University · US
• NATIONAL INSTITUTES OF HEALTH (NIH) · US
• The United States of America as represented by the Dept. of Health and Human Services (DHHS) · US

Inventors

• Philip Dormitzer · Cambridge, US
• Stephen C. Harrison · Cambridge, US
• Harry Greenberg · Washington, US
• Joshua Yoder · Newtown, US

Key dates

• Filing date: Jan 3, 2007
• Grant date: Apr 1, 2014
• Expiry date: Dec 5, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2720/12322
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel recombinant polypeptide antigens that may comprise subunit vaccines against rotavirus infection. Further, the present invention relates to methods for use of said antigens in the diagnosis, treatment and prevention of rotavirus infection.